MEDIPOSTCO.,LTD.
Develops stem cell therapeutics and regenerative medicine for incurable diseases.
078160 | KO
Overview
Corporate Details
- ISIN(s):
- KR7078160009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 대왕판교로 644번길21 -, 성남시
- Website:
- https://en.medi-post.co.kr/
- Sector:
- Manufacturing
Description
MEDIPOST is a biotechnology company specializing in the research, development, and commercialization of stem cell therapeutics and regenerative medicine. The company focuses on addressing unmet medical needs for incurable diseases through its proprietary stem cell platform technology. Its core operations include a cord blood banking service and the development of allogeneic stem cell therapies. Key commercialized products include CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. The company's clinical pipeline features next-generation injectable treatments for conditions such as osteoarthritis and diabetic nephropathy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-12-13 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2019-12-09 00:00 |
투자판단관련주요경영사항(골관절염 환자의 무릎연골결손 치료제 '카티스템' 일본 2상임상시험계획 승인)
|
Korean | 9.2 KB | ||
| 2019-12-03 00:00 |
투자판단관련주요경영사항(퇴행성관절염 연골결손치료제 ‘카티스템’의 발목관절 거골 연골/골연골 결손환자 대상 국내 3상 임상시험계획 승인)
|
Korean | 10.0 KB | ||
| 2019-11-28 00:00 |
기업설명회(IR)개최
|
Korean | 7.2 KB | ||
| 2019-11-14 00:00 |
분기보고서 (2019.09)
|
Korean | 1.3 MB | ||
| 2019-11-12 00:00 |
기업설명회(IR)개최
|
Korean | 7.1 KB | ||
| 2019-11-08 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 15.8 KB | ||
| 2019-11-04 00:00 |
기업설명회(IR)개최
|
Korean | 7.1 KB | ||
| 2019-11-04 00:00 |
기업설명회(IR)개최
|
Korean | 7.5 KB | ||
| 2019-10-23 00:00 |
기타경영사항(특허권취득)(자율공시)(세포크기에 따른 간엽줄기세포 배양방법)
|
Korean | 4.9 KB | ||
| 2019-08-22 00:00 |
기타경영사항(자율공시)(종속회사의주요경영사항)(뉴모스템® 미국FDA FAST TRACK 지정)
|
Korean | 10.5 KB | ||
| 2019-08-14 00:00 |
반기보고서 (2019.06)
|
Korean | 1.3 MB | ||
| 2019-08-12 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 692.6 KB | ||
| 2019-08-05 00:00 |
기업설명회(IR)개최
|
Korean | 7.1 KB | ||
| 2019-08-02 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 15.8 KB |
Automate Your Workflow. Get a real-time feed of all MEDIPOSTCO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MEDIPOSTCO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MEDIPOSTCO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
